DocDollars

Biosense Webster, Inc.

CA · United States · Reporting entity ID 100000005693

Total reported 2019–2025
$65.7M
#138 of 2,960 reporting companies — 0.1% of all reported industry payments
$25.7M in general payments across 128,928 records, plus $40.0M in research funding across 2,681 records.

How it breaks down

General payments $25,728,807
Research funding $39,954,375

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biosense Webster, Inc. reported $65.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #138 of 2,960 reporting companies. 61% of that was research funding and 39% general payments such as consulting, speaking, food and travel. 128,928 general payment records and 2,681 research records were filed.

Common questions about Biosense Webster, Inc.

How much has Biosense Webster, Inc. paid US doctors?

Biosense Webster, Inc. reported $65,683,182 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $25,728,807 in general payments, $39,954,375 in research funding.

How does Biosense Webster, Inc. rank among drug and device companies?

It ranks #138 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Biosense Webster, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.